Pharmafile Logo
Pharmafocus logo
Advanced Search

GlaxoSmithKline to publish trial data online

June 24, 2004

GlaxoSmithKline has announced it is to make data from all of its trials available online in an effort to counter …

News

Contract research looks East

June 24, 2004

Contract research organisations (CRO) have benefited from the pressure on the pharmaceutical industry to maintain a flow of blockbusters at …

Feature

Study finds dementia risk for HRT

June 24, 2004

A new study has found that both oestrogen-only and oestrogen plus progestogen hormone replacement therapies may increase the risk of …

News

Positive opinion on Raptiva in Europe

June 24, 2004

Raptiva, a new psoriasis treatment to be marketed by Serono in Europe has gained a positive opinion from the EMEA.The …

News

New drugs dominate NICE’s latest programme

June 24, 2004

News

Exanta launched in first market

June 23, 2004

AstraZeneca's new oral anticoagulant Exanta has been launched in Germany, its first global market.The drug is the first in a …

News

Are you structured for success?

June 18, 2004

In a world of constant change, why have many pharma companies stuck to traditional organisational structures? Are they really the …

Feature

Regulators tighten up Crestor’s European prescribing

June 17, 2004

News

Schering restructures for long-term growth

June 17, 2004

German pharmaceutical company Schering AG will no longer conduct research and development into cardiovascular or, with a few exceptions, central …

News

Cancer tsar sets out plan to end postcode prescribing

June 15, 2004

The government has promised to eliminate persistent variations in access to cancer drugs across England and Wales, and has unveiled …

News

Pharmacists to take on public health role

June 15, 2004

The government's drive to transform pharmacists into leading frontline healthcare professionals is to be spearheaded by a new consortium of …

News

Xenova’s cocaine vaccine shows promise

June 15, 2004

Cocaine addicts could be helped by a vaccine currently in development by UK biotech company Xenova, phase II results from …

News

Mental health research network launched

June 10, 2004

News

Abbott buys heart drug from Aventis for $300 million

June 10, 2004

Chicago-based Abbott Laboratories has bought the marketing and manufacturing rights for cardiovascular drug trandolapril from Aventis, in a deal worth …

News

New schizophrenia drug Abilify gets European go-ahead

June 10, 2004

Abilify, Bristol-Myers Squibb and Otsuka's antipsychotic has received European Union marketing approval and will be promoted for having fewer side …

News

Novo Nordisk claims new product superior to Lantus

June 10, 2004

News

Lipitor halves stroke risk in diabetes patients

June 8, 2004

New Lipitor data suggests the drug cut the risk of stroke by half in diabetes patients, the compelling evidence potentially …

News

Shire relocates R&D headquarters to US

June 3, 2004

Shire Pharmaceuticals has relocated its research and development headquarters to the US as the company looks to increase its penetration …

News

Oxford BioMedica one step closer to Holy Grail of nerve damage

June 3, 2004

The promise of a gene-based technology which might one day cure spinal injuries and paralysis has moved one step closer …

News

GlaxoSmithKline ‘misled doctors’ over antidepressant safety

June 3, 2004

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025